and Centrum multivitamins, making it the second-largest consumer health company in the world. Haleon is not issuing any new shares as a result of the flotation, with existing GSK shareholders ...
Pharmaceutical Technology on MSN4d
Pfizer sells 7.3% stake in Haleon for $3.3bnThe disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.
GlaxoSmithKline's consumer health business ... include Sensodyne toothpaste and Voltaren and Panadol painkillers and Centrum multivitamins – comes from the marriage of the word "hale", meaning ...
Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback